Additional file 6 of Unraveling pathogenesis, biomarkers and potential therapeutic agents for endometriosis associated with disulfidptosis based on bioinformatics analysis, machine learning and experiment validation

Zhao, Xiaoxuan, Zhao, Yang, Zhang, Yuanyuan, Fan, Qingnan, Ke, Huanxiao, Chen, Xiaowei, Jin, Linxi, Tang, Hongying, Jiang, Yuepeng, Ma, Jing
2024 · doi:10.6084/m9.figshare.26754262 · W6902270893
other OA: green CC0
🔓 Open OA copy View on OpenAlex View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-07 ⓘ

This study presents a network analysis associating signature genes with various categories of drugs, including approved, investigational, nutraceutical, and veterinary-approved medications.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Supplementary Material 6: Supplement figure 4. Candidate compound screening. The association network of signature genes with medicine. Core nodes: signature genes. Peripheral nodes: medicine. The Approved drug node color is yellow-red, the Approved and Investigational drug node color is purple-pink, the Approved, Investigational and Nutraceutical drug node color is purple-red, the Approved, Investigational and Vet approved drug node color is yellow-pink, the Approved and Vet approved drug node color is pink.

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (92)

Source provenance

openalex
last seen: 2026-05-11T08:50:40.763824+00:00
License: CC0 · commercial use OK